Clinical trials

Filters
Clear filters
1,718 trials
TrialSponsorPhaseStatusPrimary completion
PD, PK, and Safety of ALTO-203 in Patients With MDDNCT06391593Alto NeurosciencePhase 2Completed2025-04-14Actual
Phase III Study of AK112 for NSCLC PatientsNCT06396065Summit TherapeuticsPhase 3Active not recruiting2025-04-12Actual
Study That Tests AD109 in Patients Taking GLP-1 DrugsNCT06400615ApnimedPhase 2Completed2024-12-26Actual
A Strain Change Study for SARS-CoV-2 rS VaccinesNCT06409663NovavaxPhase 3Completed2024-10-15Actual
Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411379MoonLake Immunotherapeutics AGPhase 3Completed2025-08-14Actual
A Study to Evaluate the Efficacy and Safety of Subcutaneous Sonelokimab Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaNCT06411899MoonLake Immunotherapeutics AGPhase 3Completed2025-09-02Actual
A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).NCT06412666CytokineticsPhase 2, Phase 3Active not recruiting2030-01Estimated
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using SolriamfetolNCT06413433AXSMPhase 3Recruiting2026-12Estimated
Long-term Extension of GTX-102 in Angelman SyndromeNCT06415344RAREPhase 3Terminated2026-10-30Actual
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation SuspensionNCT06418711Mannkind CorporationPhase 3Terminated2025-11-10Actual
A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3GNCT06419205Akebia TherapeuticsPhase 2Recruiting2028-02Estimated
OLE Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeNCT06420297ACADPhase 3Terminated2025-12-19Actual
Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase DeficiencyNCT06422351RCKTPhase 2Suspended2029-01Estimated
Study of Olverembatinib (HQP1351) in Patients With CML-CPNCT06423911Ascentage Pharma Group Inc.Phase 3Recruiting2027-06-30Estimated
A Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye DiseaseNCT06424444ALDXPhase 3Completed2024-11-03Actual
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.NCT06429722NMRAPhase 2Completed2025-04-09Actual
ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)NCT06430385IONSPhase 1, Phase 2Recruiting2027-09Estimated
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).NCT06431776SVRAPhase 3Recruiting2027-06Estimated
A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)NCT06431893TVTXPhase 3Enrolling by invitation2030-08Estimated
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette SmokersNCT06435221Achieve Life SciencesPhase 3Completed2025-09-29Actual
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerNCT06435429Jazz PharmaceuticalsPhase 3Recruiting2028-04-28Estimated
Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a AlloimmunizationNCT06435845RallybioPhase 2Terminated2025-10-01Actual
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaNCT06445023Celldex TherapeuticsPhase 3Active not recruiting2026-08-12Actual
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or ObeseNCT06445075Scholar Rock, Inc.Phase 2Completed2025-03-04Actual
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)NCT06455202Celldex TherapeuticsPhase 3Active not recruiting2026-08-04Actual
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)NCT06456580Vor BiopharmaPhase 3Active not recruiting2027-03Estimated
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseNCT06456593ABVXPhase 2Recruiting2026-12Estimated
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerNCT06463028Faeth TherapeuticsPhase 2Recruiting2028-09Estimated
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL CancerNCT06463665Genelux CorporationPhase 2Recruiting2027-02Estimated
Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With HypoparathyroidismNCT06465108MBX BiosciencesPhase 2Completed2025-05-23Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.